APACMed Legal, Ethics & Compliance Virtual Summit

Thursday October 1st, 10am – 12pm SGT.

Join us for the annual APACMed Legal, Ethics & Compliance Virtual Summit to hear from industry thought-leaders on business-critical compliance topics.

1. Stryker's 2018 US Securities and Exchange Commission settlement

Hear from speakers – Christian Fitsch, Chief Legal Counsel, APAC, Stryker and Ryan Rohlfsen, Partner at Ropes & Gray, Co-Lead for its Anti-Corruption and International Risk practice group, and former U.S. federal prosecutor with the DOJ's FCPA criminal enforcement unit – as they discuss Stryker's settlement with the U.S. Securities and Exchange Commission (SEC) in 2018, the SEC-mandated Independent Compliance Consultant (ICC) review process, the steps taken to address the SEC's order and the ICC's findings, and some of the elements of its revised Indirect Channel Management Program following the process.

2. "Summer Reading" from Washington for FCPA Compliance

The DOJ and SEC have sustained their policymaking and enforcement programs throughout 2020 despite the coronavirus pandemic. The second edition of the Resource Guide to the US Foreign Corrupt Practices Act debuted on 3 July 2020, closely following revisions to the DOJ guidance on Evaluation of Corporate Compliance Programs on 1 June 2020. FCPA enforcement dovetails with anti-money laundering efforts, and the DOJ has advanced its controversial "China Initiative." Nate Bush, Head of DLA Piper's Asia Investigations & Competition Practices, will highlight key revisions reflecting the agencies' evolving enforcement priorities and compliance expectations—and implications for life sciences companies active in Asia.

APACMed Legal, Ethics and Compliance Committee

APACMed's Legal, Ethics & Compliance Committee is comprised of more than 70 legal/compliance professionals from over 25 member companies, with the critical purpose of supporting APACMed's objective to raise ethics and compliance standards in our industry. A key part of this is maintaining and updating APACMed's Code of Ethical Conduct. The purpose of the Code is to facilitate ethical interactions between APACMed members and those individuals and entities that use, recommend, purchase or prescribe medical technologies in the Asia Pacific region. The Committee recently completed the second Code revision​, effective as of 1 July 2020.

Learn more about APACMed's Legal, Ethics and Compliance purpose and focus areas from Tim Schmid, Company Group Chairman, Medical Devices, Asia Pacific, Johnson & Johnson and Board Sponsor, APACMed Legal, Ethics and Compliance Committee:

https://apacmed.org/our-work/legal-ethics-compliance/​